AirMax 2011 Calypte Biomedical Corporation (cbmc)

beede538wc

ypte Biomedical Corporation (CBMC) - Financial and Strategic Analysis Review
Calypte Biomedical Corporation (Calypte) is a diagnostic company engaged in the development, manufacture and marketing of in-vitro testing algorithms for improved diagnosis of HIV infection and other chronic diseases. The company provides a variety of antigens and recombinant proteins along with proprietary reagents, buffers, and other specialty products for the enhancement of immuno-diagnostic assays. The company's Aware HIV-1/2 rapid tests are used for the rapid detection of antibodies to HIV-1 and HIV Type 2. The companys flagship product [link widoczny dla zalogowanych], the Aware BED EIA used in epidemiology is the only practical way to determine HIV-1 incidence and the way it multiplies in a given location.
This comprehensive SWOT profile of Calypte Biomedical Corporation provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners [link widoczny dla zalogowanych], customers and competitors better.
This company report forms part of the Profile on Demand service, covering over 50,000 of the worlds leading companies. Once purchased, the highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Calypte Biomedical Corporation, including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days (excluding weekends).
The profile contains critical company information including*,
- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness [link widoczny dla zalogowanych], opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
For more information, please visit :
/reports/Calypte-Biomedical-Corporation-CBMC-Financial-and-Strategic-Analysis-Review-53126.html